These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20225153)

  • 1. A method to simultaneously monitor hepatitis C virus NS3 helicase and protease activities.
    Frick DN; Ginzburg O; Lam AM
    Methods Mol Biol; 2010; 587():223-33. PubMed ID: 20225153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the fused NS4A peptide-NS3 protease domain to study the importance of the helicase domain for protease inhibitor binding to hepatitis C virus NS3-NS4A.
    Thibeault D; Massariol MJ; Zhao S; Welchner E; Goudreau N; Gingras R; Llinàs-Brunet M; White PW
    Biochemistry; 2009 Feb; 48(4):744-53. PubMed ID: 19119853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C viral NS3-4A protease activity is enhanced by the NS3 helicase.
    Beran RK; Pyle AM
    J Biol Chem; 2008 Oct; 283(44):29929-37. PubMed ID: 18723512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle.
    McGivern DR; Masaki T; Lovell W; Hamlett C; Saalau-Bethell S; Graham B
    J Virol; 2015 May; 89(10):5362-70. PubMed ID: 25740995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus NS3/4A protease.
    Kwong AD; Kim JL; Rao G; Lipovsek D; Raybuck SA
    Antiviral Res; 1999 Feb; 41(1):67-84. PubMed ID: 10321580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneously Targeting the NS3 Protease and Helicase Activities for More Effective Hepatitis C Virus Therapy.
    Ndjomou J; Corby MJ; Sweeney NL; Hanson AM; Aydin C; Ali A; Schiffer CA; Li K; Frankowski KJ; Schoenen FJ; Frick DN
    ACS Chem Biol; 2015 Aug; 10(8):1887-96. PubMed ID: 25961497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins.
    Massariol MJ; Zhao S; Marquis M; Thibeault D; White PW
    Biochem Biophys Res Commun; 2010 Jan; 391(1):692-7. PubMed ID: 19944069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel recombinant single-chain hepatitis C virus NS3-NS4A protein with improved helicase activity.
    Howe AY; Chase R; Taremi SS; Risano C; Beyer B; Malcolm B; Lau JY
    Protein Sci; 1999 Jun; 8(6):1332-41. PubMed ID: 10386883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ebselen inhibits hepatitis C virus NS3 helicase binding to nucleic acid and prevents viral replication.
    Mukherjee S; Weiner WS; Schroeder CE; Simpson DS; Hanson AM; Sweeney NL; Marvin RK; Ndjomou J; Kolli R; Isailovic D; Schoenen FJ; Frick DN
    ACS Chem Biol; 2014 Oct; 9(10):2393-403. PubMed ID: 25126694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activities.
    Fukuda K; Umehara T; Sekiya S; Kunio K; Hasegawa T; Nishikawa S
    Biochem Biophys Res Commun; 2004 Dec; 325(3):670-5. PubMed ID: 15541341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorometric assay of hepatitis C virus NS3 helicase activity.
    Krawczyk M; Stankiewicz-Drogoń A; Haenni AL; Boguszewska-Chachulska A
    Methods Mol Biol; 2010; 587():211-21. PubMed ID: 20225152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase.
    Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A
    Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3.
    Umehara T; Fukuda K; Nishikawa F; Kohara M; Hasegawa T; Nishikawa S
    J Biochem; 2005 Mar; 137(3):339-47. PubMed ID: 15809335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A fluorescence-based screening assay for identification of hepatitis C virus NS3 helicase inhibitors and characterization of their inhibitory mechanism.
    Furuta A; Salam KA; Tani H; Tsuneda S; Sekiguchi Y; Akimitsu N; Noda N
    Methods Mol Biol; 2015; 1259():211-28. PubMed ID: 25579589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of hepatitis C virus NS3 protease and helicase activities through the interaction with NS4A.
    Gallinari P; Paolini C; Brennan D; Nardi C; Steinkühler C; De Francesco R
    Biochemistry; 1999 Apr; 38(17):5620-32. PubMed ID: 10220351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target.
    Raney KD; Sharma SD; Moustafa IM; Cameron CE
    J Biol Chem; 2010 Jul; 285(30):22725-31. PubMed ID: 20457607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of robust in vitro serine protease assay based on recombinant Pakistani HCV NS3-4A protease.
    Fatima K; Tahir M; Qadri I
    Virus Res; 2011 Sep; 160(1-2):230-7. PubMed ID: 21756947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase.
    Furuta A; Tsubuki M; Endoh M; Miyamoto T; Tanaka J; Salam KA; Akimitsu N; Tani H; Yamashita A; Moriishi K; Nakakoshi M; Sekiguchi Y; Tsuneda S; Noda N
    Int J Mol Sci; 2015 Aug; 16(8):18439-53. PubMed ID: 26262613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human and murine antibody recognition is focused on the ATPase/helicase, but not the protease domain of the hepatitis C virus nonstructural 3 protein.
    Chen M; Sällberg M; Sönnerborg A; Jin L; Birkett A; Peterson D; Weiland O; Milich DR
    Hepatology; 1998 Jul; 28(1):219-24. PubMed ID: 9657115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific interaction of hepatitis C virus protease/helicase NS3 with the 3'-terminal sequences of viral positive- and negative-strand RNA.
    Banerjee R; Dasgupta A
    J Virol; 2001 Feb; 75(4):1708-21. PubMed ID: 11160669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.